QTRT1

Queuine tRNA-ribosyltransferase catalytic subunit 1 · Q9BXR0 · QTRT1 on Sugi Atlas →

638 patent compounds predicted against QTRT1, 506 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL21067387 SCHEMBL21067387 0.76 2/20
SCHEMBL4308775 SCHEMBL4308775 0.33 2/20
SCHEMBL30583529 SCHEMBL30583529 0.33 2/20
SCHEMBL4316132 SCHEMBL4316132 0.32 2/20
SCHEMBL103994 SCHEMBL103994 1.00 1/20
SCHEMBL21067931 SCHEMBL21067931 1.00 1/20
SCHEMBL29941448 SCHEMBL29941448 1.00 1/20
SCHEMBL29850811 SCHEMBL29850811 0.81 1/20
SCHEMBL21068028 SCHEMBL21068028 0.79 1/20
SCHEMBL29941519 SCHEMBL29941519 0.79 1/20
SCHEMBL28693661 SCHEMBL28693661 0.78 1/20
SCHEMBL6695759 SCHEMBL6695759 0.66 1/20
SCHEMBL4311562 SCHEMBL4311562 0.62 1/20
SCHEMBL30249625 SCHEMBL30249625 0.62 1/20
SCHEMBL6654365 SCHEMBL6654365 0.62 1/20
SCHEMBL30589037 SCHEMBL30589037 0.62 1/20
SCHEMBL29723934 SCHEMBL29723934 0.61 1/20
SCHEMBL47352 SCHEMBL47352 0.61 1/20
SCHEMBL146025 SCHEMBL146025 0.61 1/20
SCHEMBL577954 SCHEMBL577954 0.61 1/20

Clinical trials — most relevant to QTRT1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Assessment of Artesunate/Mefloquine in the Peruvian Amazon PHASE4COMPLETED
Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia PHASE2/PHASE3WITHDRAWN
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies PHASE1/PHASE2RECRUITING
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor PHASE1/PHASE2NOT_YET_RECRUITING
NEO100 and High-Grade Meningioma PHASE2RECRUITING
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer PHASE2COMPLETED
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas PHASE1COMPLETED
Genetic Variability in CYP2D6 in U.S Active Duty Population PHASE1COMPLETED
Thorough QT/QTC (TQT) Clinical Trial to Evaluate the Effect of Zoliflodacin on Cardiac Repolarization in Healthy Male and Female Subjects PHASE1COMPLETED
Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors PHASE1COMPLETED
The Effect of Intermittent Rifampicin on Raltegravir PHASE1COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma PHASE1WITHDRAWN
Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers PHASE1COMPLETED
Antimalarial Drug Resistance in Mali nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer nanUNKNOWN
Choroid Plexus Dysfunction in Neurological Diseases nanRECRUITING
Evaluation of the Effects of KCNQ1 Mutation on Insulin Tolerance and Obsessive Compulsive Features in Long QT Romano-Ward Syndrome Patients. nanUNKNOWN
Effectiveness Of Rapid Diagnostic Tests in the New Context of Low Malaria Endemicity in Zanzibar nanCOMPLETED
Prevalence of Congenital Long QT Syndrome and Acquired QT Prolongation in a Hospital Cohort nanCOMPLETED
Mitoquines in COPD nanUNKNOWN
Long QT Syndrome-Population Genetics and Cardiac Studies nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Sirtuin1 in COVID19 Patients nanUNKNOWN
Evaluation of Genetic-molecular Causes of Out-of-Hospital Cardiac Arrest: From Patients to Families nanRECRUITING
The Effects of the Anesthetic Drug Propofol on the Way the Heart Recovers Between Beats nanCOMPLETED
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
Telomere Disclosure and Impact on Psychological Distress and Health Behaviors nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a QTRT1 binder may also engage these)

ProteinNameSimilarity
Q28HC6 1.000 Q28HC6 →
Q9VPY8 0.999 Q9VPY8 →
Q4QQY7 0.998 Q4QQY7 →
Q9JMA2 0.998 Q9JMA2 →
O94460 0.998 O94460 →
Q7SYK1 0.997 Q7SYK1 →
A8X0P0 0.996 A8X0P0 →
Q4QR99 0.994 Q4QR99 →
Q23623 0.988 Q23623 →
B7UVU4 0.988 B7UVU4 →
A9AW42 0.987 A9AW42 →
Q3SH61 0.987 Q3SH61 →
Q02RX7 0.986 Q02RX7 →
Q2G639 0.986 Q2G639 →
Q87EW6 0.985 Q87EW6 →
A1TVN0 0.985 A1TVN0 →
Q5P720 0.985 Q5P720 →
Q9HXH9 0.985 Q9HXH9 →
P28720 0.984 P28720 →
A1VFP3 0.984 A1VFP3 →
B2I6T4 0.983 B2I6T4 →
Q42954 0.983 Q42954 →
C4XSI9 0.983 C4XSI9 →
A6U2A7 0.983 A6U2A7 →
C0QKY2 0.983 C0QKY2 →
A5ITG3 0.983 A5ITG3 →
Q9RRB5 0.983 Q9RRB5 →
Q63707 0.983 Q63707 →
Q82VF0 0.982 Q82VF0 →
Q5QVL2 0.982 Q5QVL2 →